The Wessex Institute of Technology, located in the New Forest National Park in the South of England was established in 1986 by Professor Carlos Brebbia. The New Forest National Park is home to many beautiful villages and undisturbed natural grace and elegance.
The Wessex Institute of Technology engages in a multitude of research projects including international collaborations with universities in Spain, Italy, Brazil and others. Annually there is awarding of the Prigogine Medal, a medal established in memory of Nobel Prize winner Ilya Prigogine. A second medal, the George Green Medal, is also awarded in a joint initiative with the University of Mississippi.
To further collaboration the Wessex Institute of Technology organizes a program of conferences yearly, 2016’s program consisting of 25 separate meetings. This encourages research both professionally and academically, growing both Wessex and those it collaborates with.
BioTech is a huge sector in the health care industry today. Micro RNA is huge in Biotech. Seattle Genetics is huge in Micro RNA. Basically it uses the human genome and it’s communication network to regulate the body as as opposed to drugs and traditional methods or used in conjunction with.
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Since 1998 when Seattle Genetics was founded by Clay Siegall an entire array of cancer fighting therapies based on antibodies has been introduced to medical science.
Since a third of medical healing is said to be caused by the placebo effect it is important that a modality of treatment is accepted logically and resonates emotionally with the patient.
Particularly with a grave prognosis and facing potentially grave results doesn’t a patient deserve every chance she can get? Don’t her loved ones? Don’t we as a society that has compassion for the sick and terminally deserve that too?
A safe and effective alternative to fighting cancer based on what the body does naturally, guided by manipulating the genome with Micro RNA sequences. This most horrible of all illnesses is preventable, and treatable.
Every patient is different, and the art and science of medicine is constantly evolving. The way we look at health care, end of life care, and our attitudes towards what was once thought to be a death sentence are also concepts evolving.
Leading the way is a new breed of researchers and healthcare companies. Realizing that dream and making it a reality today is Seattle Genetics. Since 1988 under the leadership of Dr. Siegall.